Skip to main content
. 2026 Feb 28;32(4):1249–1256. doi: 10.1038/s41591-026-04263-3

Extended Data Table 6.

In tumors expressing PPARG mRNA log2[TPM + 1] > 6.1 or 7.1 (cutoffs corresponding to the provisional TPS of ≥60%), genetic alterations in PPARG, RXRA and/or FGFR3 do not provide any additional predictive value for selecting luminal lineage tumors

graphic file with name 41591_2026_4263_Tab6_ESM.jpg

Note: Log2[TPM + 1] ≥ 6.1 subset of patient population includes the Log2[TPM + 1] ≥ 7.1 subset.